Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

doi:10.1186/1750-9378-4-S2-O3

Infectious Agents and Cancer

Volume 4
Suppl 2

Viewing options:

Abstract
Full text
PDF (166KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Bruyand M
Thiebaut R
Dabis F
Lawson-Ayayi S
Joly P
Sasco AJ
Mercie P
Pellegrin JL
Geffard S
Neau D
Morlat P
Chene G
Bonnet F

on PubMed

Bruyand M
Thiebaut R
Dabis F
Lawson-Ayayi S
Joly P
Sasco AJ
Mercie P
Pellegrin JL
Geffard S
Neau D
Morlat P
Chene G
Bonnet F
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research .

Oral presentation

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

M Bruyand¹^,2, R Thiebaut¹^,2^,3, F Dabis¹^,2^,3, S Lawson-Ayayi¹^,2, P Joly³, AJ Sasco¹^,3, P Mercie¹^,2^,3^,4, JL Pellegrin²^,3^,4, S Geffard¹, D Neau²^,3^,4, P Morlat¹^,2^,3^,4, G Chene¹^,2^,3 and F Bonnet¹^,2^,3^,4 for the Goupe D'Epidemiologie Clinique Du Sida En Aquitaine (GECSA)¹^,2^,3

¹INSERM U897, Bordeaux, France

²CHU de Bordeaux, Coordination Régionale de la lutte contre l'infection due au VIH (COREVIH), Bordeaux, France

³Université Victor Segalen Bordeaux 2, Bordeaux, France

⁴Services de Médecine Interne et Maladies Infectieuses, CHU de Bordeaux, Bordeaux, France

corresponding author email

from 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research
Bethesda, MD, USA. 6–7 October 2008

Infectious Agents and Cancer 2009, 4(Suppl 2):O3doi:10.1186/1750-9378-4-S2-O3


Published:	17 June 2009

First paragraph (this article has no abstract)

The risk of neoplasis is increased in HIV-infected subjects. Beside traditional determinants of cancer occurrence, a specific role of HIV-related immunosuppression is strongly suspected and a more complex relationship between HIV and antiretroviral therapy (ART) cannot be excluded. Our objective was to disentangle the relationship between some frequently diagnosed cancers in HIV-infected patients and immunosuppression, HIV and ART exposure.